Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

BackgroundMen diagnosed with localized prostate cancer (LPC) can choose from multiple treatment regimens and are faced with a decision in which medical factors and personal preferences are important. The Personal Patient Profile-Prostate (P3P) is a computerized decision aid for men with LPC that focuses on personal preferences. We determined whether the P3P intervention improved the concordance of treatment choice with self-reported influential side-effects compared with a control group.MethodsEnglish/Spanish-speaking men diagnosed with LPC (2007–2009) from four US cities were enrolled into a randomized trial and followed through 6-months via mailed or online questionnaire. Men were randomized to receive the P3P intervention or standard education plus links to reputable websites. We classified choice as concordant if men were concerned with (a) sexual function and chose external beam radiotherapy or brachytherapy, (b) bowel function and chose prostatectomy, (c) sex, bowel, and/or bladder function and chose active surveillance, or (d) not concerned with any side effect and chose any treatment. Using logistic regression, we calculated odds ratios (OR) and 95% confidence intervals (CI) for the association between the P3P intervention and concordance.ResultsOf 448 men, most were <65 years, non-Hispanic white, had multiple physician consultations prior to enrollment, and chose a treatment discordant with concerns about potential side effects. There was no significant difference in concordance between the intervention (45%) and control (50%) group (OR = 0.82; 95%CI = 0.56, 1.2).ConclusionsThe P3P intervention did not improve concordance between potential side effects and treatment choice. Information and/or physician consultation immediately after diagnosis was likely to influence decisions despite concerns about side effects. The intervention may be more effective before the first treatment options consultation.Trial registrationNCT00692653 http://clinicaltrials.gov/ct2/show/NCT00692653

[1]  Matthew R Cooperberg,et al.  Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Barry The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer". , 2010, Archives of Internal Medicine.

[3]  A. Carson-Stevens,et al.  Re: Branney et al.: Choosing health, choosing treatment: patient choice after diagnosis of localized prostate cancer (Urology 2009;74:968-971). , 2010, Urology.

[4]  Charles D. Spielberger,et al.  State-Trait Anxiety Inventory for Adults , 2012 .

[5]  M. O'rourke,et al.  Narrowing the options: the process of deciding on prostate cancer treatment. , 1999, Cancer investigation.

[6]  P Tugwell,et al.  A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. , 1998, Patient education and counseling.

[7]  L. Carlson,et al.  Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance , 2007, BJU international.

[8]  Seth Wolpin,et al.  Development and Evaluation of the Personal Patient Profile-Prostate (P3P), a Web-Based Decision Support System for Men Newly Diagnosed With Localized Prostate Cancer , 2010, Journal of medical Internet research.

[9]  J. Steiner,et al.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote , 2006, Cancer.

[10]  Donna L Berry,et al.  Treatment decision-making by men with localized prostate cancer: the influence of personal factors. , 2003, Urologic oncology.

[11]  R. Zeckhauser,et al.  Predictors of patient preferences and treatment choices for localized prostate cancer , 2008, Cancer.

[12]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.

[13]  S. Ramsey,et al.  Why do men choose one treatment over another? , 2006, Cancer.

[14]  P. Carroll,et al.  What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. , 2007, The Journal of urology.

[15]  P. Schellhammer,et al.  Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer , 2010, BJU international.

[16]  J Concato,et al.  Treatment decisions for localized prostate cancer , 2000, Journal of General Internal Medicine.

[17]  Butler Wm,et al.  Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905. , 2006 .

[18]  J. Manola,et al.  Treatment ‘mismatch’ in early prostate cancer , 2008, Cancer.

[19]  Wadih Arap,et al.  Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.

[20]  Eric Horwitz,et al.  Decision-making strategies for patients with localized prostate cancer. , 2002, Seminars in urologic oncology.

[21]  C. Begg,et al.  Physician visits prior to treatment for clinically localized prostate cancer. , 2010, Archives of internal medicine.

[22]  R. Hays,et al.  Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease , 2003, Health and quality of life outcomes.

[23]  T. Wilt The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer. , 2012, Journal of the National Cancer Institute. Monographs.

[24]  P. Flowers,et al.  Choosing health, choosing treatment: patient choice after diagnosis of localized prostate cancer. , 2009, Urology.